News
Forbion today announced that it led the $19 million Series B financing of Escalier Biosciences BV, a privately held biopharmaceutical company.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback